Capital World Investors Ultragenyx Pharmaceutical Inc. Transaction History

Capital World Investors

$625 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $60.4 Million - $113 Million	-1,319,651 Reduced 47.71%	1,446,142 $86.3 Million
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $65,372 - $88,704	-1,051 Reduced 0.04%	2,765,793 $201 Million
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $1,253 - $1,493	-17 Reduced -0.0%	2,766,844 $233 Million
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $3,428 - $4,505	-44 Reduced -0.0%	2,766,861 $250 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $38.8 Million - $60.9 Million	-362,819 Reduced 11.59%	2,766,905 $315 Million
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $9.09 Million - $19.1 Million	-107,737 Reduced 3.33%	3,129,724 $433 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $3,503 - $4,320	48 Added 0.0%	3,237,461 $266 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $1,501 - $2,503	32 Added 0.0%	3,237,413 $253 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $2,906 - $5,409	86 Added 0.0%	3,237,381 $144 Million
Q4 2019 Feb 18, 2020	BUY	$36.08 - $45.83 $31.2 Million - $39.7 Million	865,865 Added 36.51%	3,237,295 $138 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $21.3 Million - $31.6 Million	500,858 Added 26.78%	2,371,430 $101 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $3.42 Million - $4.62 Million	62,182 Added 3.44%	1,870,572 $119 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $8.97 Million - $15.6 Million	225,000 Added 14.21%	1,808,390 $125 Million
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $4.74 Million - $9.43 Million	122,000 Added 8.35%	1,583,390 $68.8 Million
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $45.2 Million - $56.8 Million	630,088 Added 75.8%	1,461,390 $112 Million
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $15.6 Million - $27.4 Million	321,302 Added 63.0%	831,302 $63.9 Million
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $4.57 Million - $6.02 Million	105,000 Added 25.93%	510,000 $23.7 Million
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $20.2 Million - $26.9 Million	405,000	405,000 $21.6 Million

Others Institutions Holding RARE

# of Institutions

329

Shares Held

85.9M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$451 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$254 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$232 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$189 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$139 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account